Within his role as a Partner at ClearView Healthcare Partners, Mike assists clients in developing product and therapeutic area strategies and provides a unique perspective on global pricing, reimbursement, and market access. In addition to broad therapeutic area knowledge, Mike has expertise in characterizing the roles and impact of organized customers, including regulators, payers, distributors, hospital systems, and provider groups. He places significant importance on professional mentorship, client focus, and developing practical solutions for complex business needs.
Mike began his life-sciences career in genomics research before transitioning into healthcare policy and finally establishing himself in consulting. Over the last 10 years he has focused on addressing strategic business issues for leading pharmaceutical and biotechnology companies. Prior to joining ClearView, Mike held positions at Leerink Swann, Double Helix and Campbell Alliance.
Mike holds an MBA from the College of William and Mary and a Master of Public Policy focused on pharmaceutical pricing regulations from Georgetown University.
Bill Shew
David Gilman
David McClain
Debbi Amanti Belanger
Debbie Zhuang
Ketan Kapadia
Kevin Richard
Kim Goh
Klaus Bredl
Mike Rizzo
Philip Kenner
Richard Mynahan
Rishi Dalsania
Ryan Tubman
Sam Ulin
Seth Berman
Stephen Chang
Steven Chao
Stuart MacGregor
Jim Caruso
Sidnee Pinho
Kristine Hyde
Charles Mathews
Dave Konciak
Dean Griffiths
Jonathan Betts
Jonathan Hodgson
Mike Roy
Slater Hurst
Alec Marchuk
Alexander Lehrman
Allana Sanborn
Andrew Kang
Austin Hubbert
Beko Binder
Cem Salfati
Jessica Berard
Joanna Lee
Jonny Juliano
Kai-Ming Pu
Kelsey Yardumian
Maneesh Gujrati
Matthew Murphy
Matthew Pfister
Mike Murray
Olivia Piccione
Owen Im
Patrick Kuettner
Peter Goldman
Sarah Stapleton
Soyeon Park
Vini De Nadai
Steve Rubman
Lainey Miller